Furthermore, it's important to note that intronic variants at position -3 in genes like NF1, TSC1, and PAH, (as indicated by HGMD database) constitute approximately 4% of causative mutations within intronic regions. This evidence concerns the gene TSC1 and pulmonary arterial hypertension.